PW Medtech Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
249.00
255.00
183.00
888.00
576.00
-30.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
51.00
-17.00
15.00
14.00
65.00
25.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
399.00
281.00
353.00
113.00
82.00
81.00
Cash Flow from Investing Activities
-76.00
76.00
-1,297.00
3,108.00
2,319.00
-53.00
Cash Flow from Financing Activities
-228.00
-135.00
-100.00
-2,519.00
-637.00
11.00
Net Cash Inflow / Outflow
100.00
229.00
-1,049.00
702.00
1,763.00
38.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
5.00
6.00
-5.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of PW Medtech Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
249.103680486919
414.824683
-165.00
-39.95%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
51.1395859794061
-98.01764
149.00
152.17%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
399.751162283696
308.440015
91.00
29.60%
Cash Flow from Investing Activities
-76.9419449833264
-175.586451
99.00
56.18%
Cash Flow from Financing Activities
-228.001431840255
70.39146
-298.00
-423.90%
Net Cash Inflow / Outflow
100.104218930748
225.563572
-125.00
-55.62%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
5.29643347063411
22.318548
-17.00
-76.27%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 42.04% vs -20.42% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
399.75
281.45
42.04%






